Evidence map›Paper›PMID 31040348›Full record

ArticleScientific reports2019

Besnoitia besnoiti infection alters both endogenous cholesterol de novo synthesis and exogenous LDL uptake in host endothelial cells.

Liliana M R Silva, Dieter Lütjohann, Penny Hamid, Zahady D Velasquez, Katharina Kerner, Camilo Larrazabal, Klaus Failing, Carlos Hermosilla, Anja Taubert

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Animals : an open access journal from MDPI · 2025
    Review
  2. Mass Spectrometry Imaging of Lipid and Metabolite Distributions in Cysts ofJournal of the American Society for Mass Spectrometry · 2025
    Article
  3. Review
  4. Frontiers in veterinary science · 2024
    Article
  5. Novel Insights Into Sterol Uptake and Intracellular Cholesterol Trafficking DuringFrontiers in cellular and infection microbiology · 2022
    Article
  6. Article
  7. Ezetimibe blocksParasitology · 2021
    Article
  8. P-Glycoprotein Inhibitors Differently AffectPathogens (Basel, Switzerland) · 2021
    Article
  9. Parasitology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Liliana M R SilvaInstitute of Parasitology, Biomedical Research Center Seltersberg, Justus Liebig University Giessen, Schubertstr. 81, D-35392, Giessen, Germany. Liliana.Silva@vetmed.uni-giessen.de.ORCID http://orcid.org/0000-0002-2217-9983
Dieter LütjohannInstitute for Clinical Chemistry and Clinical Pharmacology, University Clinics Bonn, Laboratory for Special Lipid Diagnostics/Center Internal Medicine/Building 26/UG 68, Sigmund-Freud-Str. 25, D-53127, Bonn, Germany.
Penny HamidInstitute of Parasitology, Biomedical Research Center Seltersberg, Justus Liebig University Giessen, Schubertstr. 81, D-35392, Giessen, Germany.
Zahady D VelasquezInstitute of Parasitology, Biomedical Research Center Seltersberg, Justus Liebig University Giessen, Schubertstr. 81, D-35392, Giessen, Germany.ORCID http://orcid.org/0000-0002-1360-2209
Katharina KernerInstitute for Hygiene and Infectious Diseases of Animals, Justus-Liebig-University, Giessen, Frankfurter Str. 85-89, D-35392, Germany.
Camilo LarrazabalInstitute of Parasitology, Biomedical Research Center Seltersberg, Justus Liebig University Giessen, Schubertstr. 81, D-35392, Giessen, Germany.
Klaus FailingUnit for Biomathematics and Data Processing, Faculty of Veterinary Medicine, Justus Liebig University Giessen, Frankfurter Str. 95, D-35392, Giessen, Germany.
Carlos HermosillaInstitute of Parasitology, Biomedical Research Center Seltersberg, Justus Liebig University Giessen, Schubertstr. 81, D-35392, Giessen, Germany.
Anja TaubertInstitute of Parasitology, Biomedical Research Center Seltersberg, Justus Liebig University Giessen, Schubertstr. 81, D-35392, Giessen, Germany.
Justus-Liebig-Universität Gießen · DEUniversitas Gadjah Mada · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Besnoitia besnoiti, an apicomplexan parasite of cattle being considered as emergent in Europe, replicates fast in host endothelial cells during acute infection and is in considerable need for energy, lipids and other building blocks for offspring formation. Apicomplexa are generally considered as defective in cholesterol synthesis and have to scavenge cholesterol from their host cells for successful replication. Therefore, we here analysed the influence of B. besnoiti on host cellular endogenous cholesterol synthesis and on sterol uptake from exogenous sources. GC-MS-based profiling of cholesterol-related sterols revealed enhanced cholesterol synthesis rates in B. besnoiti-infected cells. Accordingly, lovastatin and zaragozic acid treatments diminished tachyzoite production.  Moreover, increased lipid droplet contents and enhanced cholesterol esterification was detected and inhibition of the latter significantly blocked parasite proliferation. Furthermore, artificial increase of host cellular lipid droplet disposability boosted parasite proliferation. Interestingly, lectin-like oxidized low density lipoprotein receptor 1 expression was upregulated in infected endothelial hostcells, whilst low density lipoproteins (LDL) receptor was not affected by parasite infection. However, exogenous supplementations with non-modified and acetylated LDL both boosted B. besnoiti proliferation. Overall, current data show that B. besnoiti simultaneously exploits both, endogenous cholesterol biosynthesis and cholesterol uptake from exogenous sources, during asexual replication.

Indexed as

Host-Parasite InteractionsAnimalsBiomarkersCattleCattle DiseasesCholesterolDietary SupplementsEndothelial CellsFluorescent Antibody TechniqueGas Chromatography-Mass SpectrometryHydroxymethylglutaryl-CoA Reductase InhibitorsLipid MetabolismLipidomicsLipoproteins, LDLSarcocystidaeBiomarkersCholesterolHydroxymethylglutaryl-CoA Reductase InhibitorsLipoproteins, LDL

Identifiers

PMID31040348
PMCPMC6491585
OpenAlexW2943174507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.